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Abstract 
Injectable scaffolds have great potential in special applications of regenerative 
medicine. In this study, hyaluronic acid hydrogels (HAGs) were prepared by 
crosslinking hyaluronic acid (HA) with 1,4-butanediol diglycidyl ether (BDDE). 
Applications of HAG as an injectable scaffold for regenerating functional tissues were 
proposed by matching its viscoelastic properties with those of biological tissues. The 
effect of BDDE concentration on different properties of HAGs was explored. 
Swelling properties, cross-sectional morphology, and BDDE residues of the resulting 
gels were investigated. Rheological properties of different HAGs were measured by 
monitoring their storage modulus (G’) and loss modulus (G”) and compared with 
those of biological tissues. It was shown that HAGs (BDDE from 0.4 vol% to 1.0 
vol%) possessed great water absorbing capability with swelling ratios ranging from 
99.7 to 78.9. The higher the concentration of the crosslinker used, the more rigid the 
resulting hydrogel, subsequently the lower the swelling ratio would be and the higher 
the G’ and G” values as well. Similar viscoelastic behaviors were found between 
HAGs and biological tissues, such as epidermis, dermis, articular cartilage and tooth 
germ. SEM revealed that HAG obtained at 0.4 vol% BDDE had pore diameters 
ranging from a few microns to around 100 μm with a high degree of interconnectivity. 
The feasibility of this HAG, as an injectable scaffold, to regenerate cartilage and 
dentin-pulp complex was then demonstrated using a preliminary subcutaneous 
microenvironment. The current study could be a reference to account how a 
crosslinked HA gel should be chosen for specific tissue regeneration. 
Keywords: hyaluronic acid gel, regeneration, injectable scaffold, crosslinking, 
viscoelastic  
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1. Background  
A scaffold-based tissue engineering strategy to repair or regenerate 
impaired/damaged tissues has been studied extensively in last decades, which benefits 
to the functional restoration of tissue structure and physiology.1-9 An appropriate 
scaffold should be non-toxic, bioactive, physiologically compatible, and the three 
dimensional microenvironment it provides should be favorable for cell migration and 
cellular organization into a desired tissue structure.10,11 In addition, how a scaffold is 
utilized would also influence the final outcome. Conventionally, preformed scaffolds 
with specific structures, after being combined with seeded cells/growth factors, were 
implanted into the defect sites via tedious surgical procedures.12 Injectable scaffolds, 
one of the recent focuses, can be applied by administration directly at a desired 
location in a minimally invasive manner.13,14 Obviously, the possible risk of infection 
during surgery could be minimized, while less scarring and/or pain would be 
accompanied.15 Injectability also endows a scaffold the ability to easily fill irregularly 
shaped defects, thus improving contact with surrounding tissues.14,16-18 Moreover, 
compared to pre-shaped scaffolds, seed cells and/or activity factors could be 
distributed more uniformly within injectable scaffolds before injection, simply and 
quickly by mixing.19,20 The above merits make injectable scaffolds great potential in 
special applications of regenerative medicine.21-25  
As to materials used to prepare injectable scaffolds, hyaluronic acid (HA) is one 
of favorites. As a linear polysaccharide that consists of alternating units of a repeating 
disaccharide (β-1,4-D-glucuronic acid-β-1,3-N-acetyl-D-glucosamine), HA, is found 
primarily in the (extracellular matrix) ECM and pericellular matrix, but has also been 
shown to occur intracellularly.26 The biological properties, such as biocompatibility, 
biodegradability, bioactivity and non-immunogenicity of HA along with its unique 
viscoelastic nature endow HA the very ability to mediate its activity in cellular 
signaling, wound repair, morphogenesis, and matrix/morphologic organization.26-29 In 
addition, the role of HA in some special tissues and its rich contents are of strong 
interests. For example, HA is a major component of synovial fluid and cartilage, and 
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is of great importance to maintain chondrocyte functions.30,31 HA contributes to the 
initial development of dentin matrix and dental pulp, and is beneficial to wound 
healing.32,33 HA and its derivatives have been clinically used as medical products, 
especially as skin fillers, for over three decades.34  
Depolymerization of HA chains (polysaccharides) in situ would usually occur via 
enzymatic or free radical degradation quickly and thereafter yield smaller HA units 
(oligosaccharides) which soon enter the circulatory system and are eliminated by the 
liver/kidneys. Hence, to be used as an injectable scaffold, HA should be crosslinked to 
increase its longevity to match tissue growth via different crosslinking agents. One of 
crosslinkers, 1,4-butanediol diglycidyl ether (BDDE), was used in the majority of the 
market-leading HA fillers whose stability, biodegradability, and long safety record 
have spanned more than 15 years.35 In our previous work, BDDE-crosslinked HA gels 
(HAGs) were successfully used as an injectable scaffold in the form of microparticles 
to in-situ regenerate dentin-pulp complex in porcine.1  
However, there are important questions which remain to be answered, i.e. what 
can happen when such kind of scaffold, HAG, is implanted, how can the toxic residue 
of BDDE used for crosslinking be monitored, and how its mechanical properties can 
be manipulated so as to match the target tissue as an injectable scaffold? In this work, 
BDDE crosslinked HA gels were prepared and the effect of its concentration on 
different properties of HA gels was explored. Rheological properties of different HA 
gels were measured and compared with those of biological tissues. A simple and 
sensitive method was developed to monitor the residue of BDDE within gels. After 
assessing the cytotoxicity of HA gels, its general application as an injectable scaffold 
was demonstrated. It is believed that the current study would serve as a reference to 
account how a crosslinked HA gel should be chosen for specific tissue regeneration 
and how to understand its role which might be different to traditional views on 
scaffolds.
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2. Methods  
2.1 Materials 
Hyaluronic acid sodium salt (HA, also called hyaluronan or sodium hyaluronate) 
with an average molecular weight of 1.5×106 Da, was supplied by Shangdong Freda 
Biopharm Co., Ltd. (Jinan, China) as dry powders. 1,4-butanediol diglycidyl ether 
(BDDE) was purchased from Sigma Chemical (St. Louis, MO, USA). Unless 
otherwise specified, all other chemical reagents used were supplied by Sinopharm 
Chemical Reagent, of analytical grade and used as received without further 
purification. 
2.2 Preparation of HAG via crosslinking  
HA was first dissolved in 1% NaOH at a concentration of 10 wt%, after which 
BDDE was added to the HA solution with vigorous stirring. The final concentrations 
of BDDE were 0.4 vol%, 0.6 vol%, 0.8 vol% and 1 vol%, respectively. The solution 
was then allowed to crosslink at 40 °C for 5 h, followed by being dried at room 
temperature for 3 days (Scheme 1). Phosphate buffered saline (PBS: NaCl, 9 mg/mL; 
KH2PO4, 0.03 mg/mL; Na2HPO4 × 2H2O, 0.14 mg/mL; pH=7) of 500 mL was then 
added to the above crosslinked HA or HAG to make it swell, after which HAG was 
put into dialysis bag and dialyzed sequentially with excessive deionized (DI) water 
and PBS to remove the residual BDDE. The resulting gel was adjusted with PBS to 
obtain HAG with a HA concentration of 20 mg/mL and then smashed with a 
homogenizer to obtain gel particles of 0-400 μm. Before being used, the obtained 
injectable HAG scaffold was sterilized in a high-pressure steam sterilizer set at 
120 °C, 20 min. 
2.3 Swelling behaviors of HAG  
To examine the swelling behaviors, hydrogels prepared under different BDDE 
concentrations were soaked, respectively, in DI water at 37 °C until swelling 
equilibrium had been reached. The hydrogels were then taken out and weighed 
(BSA124S, Sartorius, Goettingen, Germany) after the removal of excess water on 
their surfaces with filter papers. The hydrogels were dried under vacuum at room 
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temperature for 3 days to achieve constant weight. The equilibrium swelling ratio (SR) 
was calculated based on the following equation: 
0
0S
W
WW(SR)ratioSwelling −=  
Where Ws and W0 are the weights of the swollen hydrogel and the corresponding 
dried hydrogel, respectively. All experiments were performed in triplicate and 
swelling ratios were given without units as mean ± standard error of mean. 
2.4 Rheological analysis of porcine tissues and HAGs 
The rheological properties were elucidated by dynamic oscillatory measurements 
using an Anton Paar-Physica MCR 301 Rheometer (Anton Paar GmbH, Germany) 
with a 25 mm diameter parallel plate geometry (PP25). The epidermis (face), dermis 
(face), and articular cartilage from adult porcine, tooth germ obtained from newly 
born pigs, and different HAGs (after sterilization) were carefully placed into the lower 
plate after which the upper plate was lowered to a 1 mm gap. After that, dynamical 
oscillatory frequency sweeps for porcine tissues and HAGs were performed at 37 °C 
(physiological temperature) with constant strain (1%) and the frequency was set from 
0.1 to 10 Hz. The storage modulus (G’) and loss modulus (G”) as a function of 
frequency were recorded by the associated software.  
2.5 Morphology of cross-sections of HAGs 
Cross-sections of hydrogels obtained from different concentrations of BDDE 
were characterized by scanning electron microscopy (SEM). Briefly, after reaching 
swelling equilibrium, hydrogels were quickly frozen in liquid nitrogen and fractured 
quickly followed by being freeze-dried for 48 h. After being coated with an ultrathin 
layer of gold/Pt, the cross-sectional morphologies of the lyophilized gels were 
observed by a Nova Nano SEM (Tokyo, Japan). 
2.6 Determination of BDDE residues within HAGs 
A highly sensitive method based on fluorescent spectrophotometry was applied 
to determine the amount of BDDE.36 This method makes use of strong fluorescent 
substance produced by BDDE and nicotinamide where excitation wavelength and 
emission wavelength were located at 370 nm and 430 nm, respectively. The 
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fluorescent intensity appeared, which can be detected using a fluorescent 
spectrophotometer, is proportional to the amount of BDDE. 
Each freshly prepared HAG sample (prepared from 0.5 g HA crosslinked with 
different amounts of BDDE) in its swelling equilibrium was added with a soaking 
solution of 50 mL DI water. The samples were then shaken at a speed of 50 rpm using 
a shaking table (HY-5, Jiangsu, China) at room temperature and the DI water was 
renewed every 24 h. The soaking solution of 200 μL was mixed with a freshly 
prepared nicotinamide solution (100 μL, 125 mmol L-1). The mixed solution was 
incubated in a water bath at 37 oC for 120 min. After that, acetophenone solution (1 
mL, 15 vol% in ethanol) and potassium hydroxide solution (1 mL, 1 mol L-1) were 
added into the above mixture. After being incubated in an ice bath for 10 min, formic 
acid (5 mL) was added into this mixture, which was then heated at 60 oC using a 
water bath for 5 min and subsequently cooled in an ice bath for 10 min. The resulting 
solution after being kept at room temperature for 15 min was finally subjected to 
fluorescent intensity recording using a fluorescent spectrophotometer (Cary Eclipse, 
USA) with an excitation wavelength at 370 nm and an emission wavelength at 430 
nm. A standard curve using serial dilutions of BDDE was first established to 
determine the relationship between the fluorescent intensity and BDDE concentration. 
As determined, the method has an excellent linear range of 0.5-8.0 μg mL-1 BDDE. 
Below the low threshold, the intensity was undetectable with high background 
interference. The determined BDDE concentration of the soak solution was termed as 
the released amount based on the soaking times as shown in Table 1. Each 
measurement was performed in triplicate and the average values were reported. 
2.7 Cytotoxicity of HAG on human fibroblasts 
This study was approved by the ethic committee of Shanghai Ninth People's 
Hospital Affiliated School of Medicine of Shanghai Jiao Tong University and 
informed consent from all of the patients was obtained. Fresh human foreskin 
specimens were obtained from donors (aged from 5 to 12 years) who received a 
routine circumcision procedure at Shanghai Children’s Hospital, China. The 
specimens were washed with sterile phosphate-buffered saline (PBS), and cut into 
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small pieces (1-2 mm3) which were then digested with 0.1% dispase (Worthington, 
Lakewood, NJ) at 4 °C overnight. The epidermal layers were removed, and the 
remaining dermal parts were further digested with 0.1% collagenase (Worthington, 
Lakewood, NJ) in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, USA) 
for 3 h by gentle agitation at 37 °C. The digested cells were then forced to pass 
through a 100 μm cell strainer (BD Biosciences, USA) and further centrifuged 
(Allegra 64R Centrifuge, Beckman Coulter, California, USA) at 1500 rpm for 5 min. 
The cells were collected by resuspension in low-glucose DMEM supplemented with 
10% fetal bovine serum (FBS, Hyclone, USA), L-glutamine (300 mg/mL), vitamin C 
(50 mg/mL), penicillin (100 U/mL), and streptomycin (100 mg/mL) (all from 
Sigma-Aldrich, USA). After the cell suspension was plated for 24 h, the plates were 
washed thoroughly with PBS to remove residual non-adherent cells. When 90% 
confluence was reached, cells were detached and subcultured at 1×104 cells/cm2 in the 
culture plates. For the following experiment, cells of passage 3-5 were used.  
The in vitro cytotoxicity tests of HAG obtained from 0.4% BDDE concentration 
was determined by 3-(4,5-dimcthylthioazol-2-yl)-2,5-diphenyl-tetrazolium bromide 
(MTT) assay. The above cells in their logarithmic growth were seeded at a density of 
5000 cells per well in 96-well plates with 100 μL of culture medium. After 24 h of 
incubation, the medium was removed. The cells were incubated with 100 μL of the 
above culture medium (negative control), or 100 μL medium containing either 0.5 
mg/mL or 1 mg/mL cross-linked HA gels, or 100 μL medium containing 64 mg/mL 
phenol (positive control), respectively. Cells were incubated with these treatments for 
2 d, 4 d or 7 d, respectively, and the respective viability of cells was then determined 
by MTT assay. Briefly, 20 μL of MTT (5 mg/mL in Ca2+ and Mg2+ free PBS, Sigma, 
St. Louis, MO, USA) was added to each well at the time of incubation and the cells 
were incubated for another 4 h at 37 oC for MTT formazan formation. The medium 
was then removed carefully and 200 μL dimethyl sulfoxide (DMSO, Sigma) was 
added to each well to dissolve the formazan crystals. The plates were shaken for 10 
min and then the absorbance at a wavelength of 490 nm of each well was read on in a 
spectrophotometric DIA reader (Elx 800G, DIALAB GMBH, Vienna, Austria). Data 
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were presented as mean ± standard error from three individuals, and each of them was 
the mean of triplicate experiments. 
2.8 Microscopic observation of HAG injectable scaffold and its subcutaneous 
degradation in nude mice 
In order to have a gross morphology observation, the injectable HAG scaffold 
was added with a few drops of black ink, followed by being observed under a 
florescent microscope (DYF-330C, Shanghai, China). The above injectable HAG 
scaffold (0.2 mL) was injected subcutaneously into the dorsum of ~5 weeks old male 
nude mice either for 15 or 36 weeks to evaluate its degradation condition with time. 
2.9 Regeneration of cartilage-like tissue subcutaneously in nude mice using 
injectable HAG scaffold 
The surgical procedures were permitted by the Animal Care and Experimental 
Committee of School of Medicine, Shanghai Jiao Tong University. Cartilage tissue 
was harvested in sterile conditions from the articular cartilage of the pigs that were 
euthanized with an overdose of pentobarbital (100 mg kg−1 IV) according to the 
method reported previously.37-39 The articular cartilage was cut into 2 × 2 × 1 mm3 
slices and washed twice with PBS. After being digested with 0.25% trypsin plus 
0.02% EDTA (HyClone, USA) at 37 °C for 30 min, the cartilage slices were further 
digested at 37 °C with 0.1% (w/v) collagenase II for 12-16 h. The resulting 
chondrocytes were harvested, counted, and seeded onto culture dishes at a cell density 
of 2.5 × 104 cells cm−2 for culture and subculture in DMEM with 10% fetal bovine 
serum (FBS) (Hyclone, USA). The chondrocytes were expanded to Passage 1 for 
further experiments. The above cultured first passage chondrocytes were mixed with 
HAG scaffold (pre-incubated at 37 oC for 3 h) at a ratio of 2×107 cells/mL scaffold. 
The resulting cell-scaffold composites were immediately injected subcutaneously into 
the dorsum of ~5 weeks old male nude mice.  
2.10 Regeneration of dentin-pulp complex subcutaneously in nude mice using 
injectable HAG scaffold 
Tooth buds were isolated from jaws of newly born porcine and washed with 
0.25% chloramphenicol solution for 3 times. The tooth bud tissue was then minced 
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into pieces (< 2 mm3) , and enzymatically treated with 0.15% collagenase (NB4 
Standard Grade, SERVA) and 0.5 U/mL dispase II (Neutral protease, Roche) in 
DMEM/F12 (1:1) (HyClone) with 15% fetal bovine serum (FBS) (HyClone) for 1.5 h 
at 37 °C. After that, the digested tooth bud tissues were strained with nylon filter 
(100-μm pores) and the harvested primary individual dental bud cells were cultured 
with DMEM/F12 (1:1) with 15% FBS and antibiotic/antimycotic solution (300/mL 
penicillin G, 300 μg/mL streptomycin, 0.75 μg/mL amphotericin B) (HyClone) at an 
incubator at 37 °C with 5% CO2.40 These cells were cultured for 5~7 days before 
reaching confluence and they formed a mixed population of epithelial- and 
fibroblast-like cells. The cells were then digested with 0.25% trypsin for 1~2 min, 
whereby dental mesenchymal cells (DMCs) were digested and most of epithelial cells 
were still adherent to the plastic surface of the cell culture dish. The digested cells 
were further cultured in the above medium without any antibiotic/antimycotics. Due 
to the difference in the sensitivity to trypsin and medium requirement, the residual 
epithelial cells gradually lost from the culture, leaving only the mesenchymal cells.41 
DMCs of passage 3 were used for further experiments.  
The above cultured third passage DMCs were mixed with HAG scaffold 
(pre-incubated at 37 oC for 3 h) at a ratio of 5×107 cells/mL scaffold, further 
supplemented with BMP-4 of different concentrations (25 μg/mL, 12.5 μg/mL and 
6.25 μg/mL respectively). The resulting cell-scaffold composites were immediately 
injected subcutaneously into the dorsum of ~5 weeks old male nude mice.  
2.11 Histology and immunohistochemical analysis 
When the samples were harvested, the animals were treated with euthanasia. The 
samples were then removed and washed with PBS, followed by being fixed in 4% 
paraformaldehyde at 4 oC for 24 h, demineralized with 10% EDTA at room 
temperature for several months (mineralized tissue). Samples were processed for 
paraffin sectioning, and the sections (5 μm-thick) were performed hematoxylin-eosin 
(H&E), Masson (MAIXIN.BIO) and immunohistochemical staining. The primary 
antibody used for the immunohistochemical analysis was rabbit anti-human dentin 
sialoprotein (DSP) polyclonal antibody (H-300) (1:100 dilution) (Santa Cruz). The 
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second antibody used was Envision+ system-HRP labeled polymer anti-rabbit (Dako), 
and liquid DAB+ substrate chromogen system (Dako) was used as well. 
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3 Results and discussion 
3.1 Swelling behaviors of HAG  
To reveal the effect of BDDE concentration on the swelling properties of 
hydrogels, HAGs after crosslinking were immersed in DI water to reach their 
corresponding equilibria which were monitored by mass at room temperature. As 
displayed in Fig. 1, all HAGs possessed great water absorbing capability. At the 
lowest BDDE concentration used (0.4 vol%), the HAG had a swelling ratio of around 
100. With the increase in BDDE concentration, swelling ratio of the resulting HAGs 
decreased correspondingly. When the highest BDDE concentration was used (1.0 
vol%), the swelling ratio of respective HAG was decreased to 78.9. Significant 
difference was observed in the swelling ratios of HAGs obtained from 0.4 vol% and 
0.6 vol% (p < 0.05, Fig. 1). This was also the case for samples obtained from 0.6 
vol% and 0.8 vol% (p < 0.05, Fig. 1), whereas no significant difference was observed 
in the swelling ratio between samples obtained from 0.8 vol% and 1.0 vol% (p > 0.05, 
Fig. 1). It could be expected that the higher the concentration of BDDE used, the more 
the rigidity of the resulting hydrogel, as more crosslinking points would be yielded. 
The higher the rigidity of the hydrogel, the lower the swelling ratio was. But it would 
be possible that at BDDE concentrations higher than 0.8 vol%, this trend was 
compromised by the BDDE crosslinking efficiency. Obviously, BDDE concentration 
in the above range is one of key factors in controlling swelling ratio of HAG.  
3.2 Rheological properties of porcine tissues and HAGs  
The rheological properties of HAGs were characterized by monitoring the 
storage modulus (G’) and loss modulus (G”) as a function of frequency through 
rheometry, which revealed the effect of BDDE concentration used for crosslinking on 
the viscoelasticity of HAGs (Fig. 2a and b). G’ and G” of different HAGs exhibited 
similar nonlinear rheological behaviors whose values increased with the increase in 
frequencies, implying the existence of a similar microstructure. It was noted clearly 
that for each HAG, G’ was far higher than G” in the range of whole frequencies, 
which means the majority of the energy was stored in the deformation of hydrogel 
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itself. The highly elastic nature of these hydrogels was thus indicated. It was also 
displayed in Fig. 2a and b that both G’ and G” values increase with the increasing 
BDDE concentration from 0.4 vol% to 1.0 vol% within the tested frequency range.  
It was revealed that the local matrix stiffness on cells has important implications 
for their development, differentiation, disease and regeneration.42 At the macro scale, 
elasticity is evident in a solid tissue that can recover its shape within seconds after 
mild poking and pinching, or even after sustained compression. At the cellular scale, 
normal tissue cells probe elasticity as they anchor and pull on their surroundings. A 
normal tissue cell not only applies forces, but also responds through cytoskeleton 
organization to the resistance that the cell senses, regardless of whether the resistance 
derives from normal tissue matrix, synthetic substrate, or even an adjacent cell.42,43 It 
was thus suggested that mechanical properties of the substrate or scaffold can 
profoundly affect cell locomotion, growth, and differentiation, and scaffolds with 
similar elasticity to target tissue would be preferable for regeneration.42-44 Therefore, 
the viscoelastic properties of HAGs were thus compared with some tissues, such as 
epidermis, dermis, articular cartilage and tooth germ, in order to verify their 
feasibility as injectable scaffolds for tissue regeneration. As displayed in Fig. 3a and b, 
dynamic oscillatory frequency sweep curves (G’ and G”) for epidermis, dermis, 
articular cartilage and tooth germ exhibited similar nonlinear rheological behaviors to 
those of HA hydrogels (Fig. 2a and b), indicating the similar viscoelastic properties. 
By simply varying the BDDE concentration, it would be possible to obtain HA 
hydrogels that possess close viscoelastic properties to those of specific tissues.  
HA has been approved by the Food and Drug Administration (FDA) simply as a 
dermal filler. In 2006, cosmetic injections of HA were known to be the second most 
popular non-surgical procedure for women and the third most popular procedure for 
men.45-48 To overcome its short half-life, HA is chemically crosslinked to extend 
duration as a dermal filler via different crosslinkers or different procedures.49 As a 
dermal filler, HA or HAG is not involved in the structure of collagen and does not 
enhance the shortage of HA in aged skin, but simply works by augmenting 
volume.45,50 In the current work, it’s the role of HAG as a filler, especially as a 
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cell-delivery filler to augment volume could stand based on its similar viscoelastic 
properties to both epidermis or dermis.  
Among the natural polymers, HA was proven to be of fundamental priority for 
cartilage homeostasis and chondrocyte microenvironment. Therefore, series of HA 
derivatives have long been investigated as scaffolds or delivery matrixes for cartilage 
repair. For example, PEGDA crosslinked thiolated HA and gelatin were used for cell 
therapy to deliver mesenchymal stem cells to full-thickness defects in the patellar 
groove of rabbit femoral articular cartilage.51 Elisseeff et al. pioneered the use of a 
photopolymerization process for the encapsulation of chondrocytes in HA based 
hydrogel networks for treating damaged cartilage tissue.52-54 However, these HA 
hydrogels were clinically impractical because of the complexity of the chemistry and 
toxicity of preparation. Most of those HA based developments were just served as 
preclinical usages, as from a regulatory point of view, the involved chemistry might 
be problematic for development of a clinical product for cell delivery, even though 
their biological activities were preserved.55 Regarding our current developed HAG, 
firstly the BDDE was already used in the majority of the market-leading HA fillers 
whose stability, biodegradability, and long safety record have spanned more than 15 
years. Secondly, the BDDE residue could be carefully monitored. Thirdly, the 
crosslinking process was relatively simple and could be easily scaled up.  
3.3 Morphology of cross-sections of HAGs 
The morphological structure of HAGs was demonstrated by observing the 
cross-sections of lyophilized samples via SEM as shown in Fig. 4. It was found that 
all HAGs had a quite homogeneous porous structure. As to the HAG obtained from 
0.4 vol%, the pores were well interconnected and formed an interconnected 
honeycomb structure (Fig. 4 A1 and A2). The degree of interconnectivity decreased 
with the increase in BDDE concentration used for obtaining HAGs (Fig. 4 A1-D1, 
A2-D2). Moreover, at the highest BDDE concentration, the porous structure was quite 
compact with the lowest degree of interconnectivity (Fig. 4 D1 and D2). It seems that 
the mean pore size of the porous network decreased with the increase in BDDE 
concentration. For instance, samples obtained from 0.4 vol% BDDE exhibited a mean 
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pore size of around 100 μm (Fig. 4 A2), which was gradually reduced to 
approximately 50 μm when BDDE concentration was increased to 1.0 vol% (Fig. 4 
D2). Most probably, it was due to the fact that more crosslinking points were achieved 
within the HA macromolecular chains at a higher BDDE concentration. Since 
interconnectivity was very important for cellular communication and cell growth,56,57 
HAG obtained at 0.4 vol% BDDE with a mean pore size of 100 μm was selected for 
the following in vitro and in vivo evaluation as an injectable scaffold.  
3.4 BDDE residues within HAG 
Since BDDE itself was toxic, it is necessary to monitor its residue amount within 
the HAGs. As shown in Table 1, for all samples, the first released amounts of BDDE 
were higher than their respective following release. The reason for this might be that a 
thimbleful of residual BDDE could easily escape from the highly porous network 
structure when immersed in DI water. Reasonably, the released amount increased with 
the increase in BDDE concentration. Moreover, the fourth release of HA hydrogel 
(0.4 vol%) was already under the detection limit, suggesting that the residual BDDE 
of this sample had readily been removed. The relatively easy removal of toxic 
residues further ensured the suitability of this HAG as an injectable scaffold in the 
following applications. 
3.5 Gross morphology and cytotoxicity of HAG on human fibroblasts 
The particles size of prepared HAG was in the range of 0-400 μm (Fig. 5a and b). 
These gels in the form of irregular microparticles could be easily injected via a 
syringe (30G), facilitated by their elastic nature as determined by their rheological 
test. 
The viabilities of cells incubated with the negative control (culture medium), 0.5 
mg/mL, 1 mg/mL HAG (0.4 vol% BDDE) and the positive control (culture medium 
containing phenol) for 2 d, 4 d and 7 d are shown in Fig. 6. At the time point of 2 d, 
no significant difference in the absorbance can be observed between any two groups. 
With the increase in culture time to 4 d, the absorbance of negative control increased, 
whereas the one of positive control decreased significantly compared to their 
respective values at 2 d. The absorbance of either 0.5 mg/mL HAG group or 1 mg/mL 
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HAG group had a similar trend of increase from 2 d to 4 d to that of the negative 
control. There was a minor increase in absorbance of the 1 mg/mL HAG group was 
comparable with that of the negative control at 4 d (P < 0.05), but no difference in 
absorbance was observed between the 0.5 mg/mL HAG group and 1 mg/mL HAG 
group (P > 0.05). With the further increase in culture time to 7 d, the absorbance of 
negative control kept on increasing. This was also the case for 0.5 mg/mL and 1 
mg/mL HAG groups, indicating that cells within these two groups were in a similar 
growth rate to those in culture medium. No significant difference was observed 
between negative control and 0.5 mg/mL group (P > 0.05), or negative control and 1 
mg/mL group (P > 0.05). The one of positive control at 7 d was at a low absorbance 
which is close to the background level. Therefore, non-cytotoxicity nature of the 
injectable HAG scaffold could be confirmed. 
3.6 Degradation of injectable HAG scaffold subcutaneously in nude mice 
Gross views of pristine injectable HAG scaffold 15 and 36 weeks after being 
injected subcutaneously in nude mice are shown in Fig. 7 A and B, respectively. No 
tissue growth within the scaffold could be located except a thin layer of fibrous 
encapsulation both at 15 (Fig. 7 A1-A3) and 36 weeks (Fig. 7 B1-B3) according to 
their respective histological staining. At both time points, HAG (green arrow head) 
with a high content of water still occupied the whole samples, but most of the HAG 
fragments would be lost during H&E processing (Fig. 7 A1, A2, B1 and B2). 
Degradation with time could be indicated since the same amount of HAG had 
experienced shrinkage in its volume with time (Fig. 7 A and B). These results then 
were consistent with the statement mentioned above that as a dermal filler, HA or 
HAG is not involved in the structure of collagen and does not enhance the shortage of 
HA in aged skin, but simply works by augmenting volume.45,50 
3.7 Regeneration of cartilage-like tissue subcutaneously in nude mice using 
injectable HAG scaffold 
The in vivo construction condition before sample harvest is shown in Fig. 8 A. 
The harvested sample in shown in the inset here, suggesting that the initial fluent 
cell-scaffold complex already turned into a solid tissue for 12 weeks after being 
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constructed subcutaneously in nude mice. The further histological overall view and 
high magnification observation are shown in Fig. 8 B and C, respectively. Lacuna-like 
structure, typical cartilage characteristics, in the whole sample can easily be located. 
HAG fragments still remained within the sample. 
3.8 Regeneration of dentin-pulp complex subcutaneously in nude mice 
The in vivo construction process immediately after injection and before sample 
harvest of the constructs (DMCs+HAG+BMP-4) is shown in Fig. 9 A and B. From the 
gross views of the samples harvested, it can be observed that the initial cell/scaffold 
composites supplemented with different concentrations of BMP-4 were already 
mineralized at the time when they were harvested as shown in Fig. 9 C, D and E. 
Therefore, before they were further subjected to histological staining, 
demineralization was necessary for obtaining paraffin slices. 
Overall views of H&E staining of the regenerated tissues are shown in Fig. 10 A, 
B and C, respectively (A: 25 μg/mL, B: 12.5 μg/mL, C: 6.25 μg/mL). All of the 
samples obtained from different concentrations of BMP-4 exhibited island-like 
features (Fig. 10 A-C). As to the sample obtained from the highest amount of BMP4, 
within localized areas of higher magnifications (Fig. 10 A1, A2 and A3), there were 
well organized dentinal tubules (white arrow head), columnar odontoblast-like cells 
(yellow arrow head) with polarized basal nuclei and blood vessels (black arrow head). 
Those cells (yellow arrow head) aligned against the regenerated dentin-like tissue, 
while those dentinal tubules (white arrow head) arranged radially from the pulp-like 
tissue. The above was typical dentin-pulp like features. When the BMP4 
concentration was lowered to 12.5 μg/mL, the organization of those dentinal tubules 
was not as orderly as that of 25 μg/mL (Fig. 10 B1-B3). Moreover, the cell density 
within dentin-like area was higher than that in similar area of Fig. 10 A1-A3. 
However, with the further decrease in BMP4 concentration to 6.25 μg/mL, although 
the above dentin-pulp like feature could still be observed, bony-like tissue formation 
with hypertrophic cells was also located within the sample as shown in Fig. 10 C1 and 
C3. It could be indicated from the above phenomenon that insufficient odontoblast 
differentiation of the injected DMCs might occur at the lowest concentration of BMP4 
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used, thereby affecting the uniformity of the whole sample. 
Masson and immunohistochemical staining (Fig. 11) further demonstrated the 
above condition. That is, regeneration of island-like tissues in all groups (25 μg/mL in 
Fig. 11 A and D; 12.5 μg/mL in Fig. 11 B and E; 6.25 μg/mL in Fig. 11 C and F) could 
be confirmed. Comparing the respective views of higher magnification (Fig. 11 
A1-F1), the sample of 25 μg/mL had the best organized and mature dentinal tubules 
with strong staining for DSP (Fig. 11 A1 and D1). Polarized histological morphology 
of the regenerated tissues (Fig. 12 A-C) further confirmed the presence and 
organization of dentinal tubules of the three groups. Again, those well organized 
dentinal tubules could well be observed (Fig. 12 A), and such kind of structure 
became more and more compromised with the decrease in BMP4 concentration (Fig. 
12 B). 
A few reasons might account for why BMP-4 was chosen as a growth factor to 
initiate the above dentin-pulp regeneration process. First, it was reported that BMP-4 
plays important roles in tooth development by participating in reciprocal 
epitheliomesenchymal induction and interaction.58 It is also a crucial mesenchymal 
odontogenic signal which drives tooth morphogenesis through the bud-to-cap 
transition during tooth development.59 Moreover, BMP-4 coordinated both the 
processes of dentin and enamel formation through both paracrine and autocrine ways 
in odontoblasts.60,61 Due to its important roles mentioned in tooth morphogenesis, 
BMP-4 was taken as a morphogen to promote dentin-pulp complex regeneration in 
this work. As confirmed by current results, well vascularized dentin-pulp complex 
regeneration in nude mice model was achieved after the injection composed of HAG, 
DMCs and BMP-4 at an appropriate dosage. Second, it was shown in our previous 
study that when DMCs were combined with HAG scaffold and TGF-β1, dentin-pulp 
complex could be regenerated in nude mice, tooth slice models and even in situ in the 
empty pulp chamber of mini pigs.1 In addition to identify that BMP-4 could also 
fulfill the similar task, the current work also confirmed the role of HAG. That is, HAG 
only acted as a delivery vehicle and also facilitated the non-specific morphogenesis as 
a three-dimensional hydrogel scaffold, and there was no special interaction between 
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HAG and TGF-β1. The role of HGA as a general scaffold could be thus indicated and 
its primary role appeared to be retention of cells, thereby facilitating the expected 
biological repair processes and morphogenesis. 
Finally, it should be mentioned that the degradation of HAG could be tuned by 
the microenvironment, the presence of cells and cell physiological states. As to the 
implantation of pristine HAG, the duration was the longest among the three tried 
implantation conditions. It is possible that HAG could possibly have the flexibility to 
adjust its degradation under different environments. That is, cells or extracellular 
matrix within HAG scaffold could easily help to adjust its turnover, probably due to 
the biological nature of HA.
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4. Conclusions  
An HA based injectable scaffold has been successfully prepared by a 
crosslinking reaction of BDDE with HA to obtain HAG. The crosslinking degree 
could be adjusted simply by varying BDDE concentration. The higher the 
concentration of the crosslinker used, the more rigid the resulting hydrogel, 
subsequently the lower the swelling ratio would be and the higher the G’ and G” 
values as well. Similar viscoelastic behaviors were found between HAGs and 
biological tissues, such as epidermis, dermis, articular cartilage and tooth germ, which 
accounts for the feasibility of using such HAG as an injectable scaffold for these 
tissue regeneration. HAG obtained at 0.4 vol% BDDE had pore diameters ranging 
from a few microns to around 100 μm with a high degree of interconnectivity, which 
was then demonstrated to be suitable for cartilage and pulp-dentin regeneration. The 
current study not only gave the detail on preparation, but could also be a reference to 
account how a crosslinked HA gel should be chosen for specific tissue regeneration. 
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Figure Captions: 
Figure 1. Swelling ratio of HA hydrogels crosslinked with different concentrations of 
BDDE. BDDE concentrations used to crosslink HA were 0.4 vol%, 0.6 vol%, 0.8 
vol% and1.0 vol%, respectively. 
Figure 2. Dynamic oscillatory frequency sweep curves for HA hydrogels crosslinked 
with different concentrations of BDDE. Storage modulus (a) and loss modulus (b) at 
37 oC as a function of frequency (Hz) for HA hydrogels crosslinked with different 
concentrations of BDDE (0.4 vol%, 0.6 vol%, 0.8 vol%, 1.0 vol%).  
Figure 3. Dynamic oscillatory frequency sweep curves for porcine epidermis, dermis, 
cartilage and tooth germ. Storage modulus (a) and loss modulus (b) at 37 oC as a 
function of frequency (Hz) for epidermis, dermis, cartilage and tooth germ, 
respectively. 
Figure 4. Scanning electron microscopic images of the cross-section of HA hydrogels 
crosslinked with different concentrations of BDDE. BDDE concentrations used to 
crosslink HA were 0.4 vol% (A1, A2), 0.6 vol% (B1, B2), 0.8 vol% (C1, C2) and 1.0 
vol% (D1, D2), respectively.  
Figure 5. Microscopic images of HA injectable gel particles. HA injectable gel 
particles were prepared by being crosslinked with 0.4 vol% BDDE. (B) is a higher 
magnification view of (A). 
Figure 6. In vitro cytotoxicity assay of HA gel on human fibroblasts. Human 
fibroblasts in their logarithmic growth were seeded at a density of 5 × 103 cells per 
well in 96-well plates with 100 μL of culture medium, respectively. After 24 h of 
incubation, the medium was replaced with 100 μL of the above culture medium 
(negative control), or 100 μL medium containing either 0.5 mg/mL or 1 mg/mL HA 
gels, or 100 μL medium containing 64 mg/mL phenol (positive control), respectively. 
Cells were incubated with these treatments for 2 d, 4 d or 7 d, respectively, and the 
respective viability of cells was then determined by MTT assay. HA gel was 
cross-linked by 0.4 vol% BDDE concentration. Values are the absorbance of each 
well at a wavelength of 490 nm, expressed as mean ± sd of three experiments, assayed 
in quintuple. The level of significance was set at P < 0.05. *P < 0.05 vs. negative 
control, ?P < 0.05 vs. positive control, #P < 0.05 vs. 0.5 mg/mL. 
Figure 7. Gross view and histological analysis of HAG scaffolds injected 
subcutaneously in nude mice for 15 and 36 weeks. A and B were gross views of the 
samples injected for 15 and 36 weeks, respectively. A1 and B1 were overall views of 
H&E staining of the samples injected for 15 and 36 weeks, respectively. A2 and A3, 
B2 and B3 were higher magnification observations of the localized square areas 
within A and B, respectively. No specific tissue was regenerated in HAG scaffold 
injected either for 15 (A2-A3) or 36 (B2-B3) weeks. A few fibroblasts encapsulating 
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the HAG scaffolds could be observed at both time points (A3, B3). HAG fragments 
were labeled by green arrow heads. Scale bars: 1000 μm for A1 and B1; 50 μm for 
A2-A3 and B2-B3. 
Figure 8. Regeneration of cartilage-like tissue using HAG. (A) In vivo construction 
process after being injected subcutaneously in nude mice. The inset in (A) was the 
gross view of the tissue harvested after being constructed subcutaneously in nude 
mice for 12 weeks. The tissues were constructed using chondrocytes (2×107 cells/mL) 
and HAG. (B) Overall view of H&E staining of the regenerated tissue. (C) was the 
localized square area of higher magnification observation within (B). Scale bars: 1000 
μm for B; 100 μm for C. 
Figure 9. Regeneration of dentin-pulp like tissue using HAG. In vivo construction 
process immediately after injection (A) and before sample harvest (B). Gross views of 
regenerated tissues constructed subcutaneously in nude mice for 10 weeks using 
DMCs (5×107 cells/mL), HAG, and BMP-4 of 25 μg/mL (C), 12.5 μg/mL (D), and 
6.25 μg/mL (E), respectively.  
Figure 10. Histological analysis of the regenerated tissue constructed subcutaneously 
in nude mice for 10 weeks. The tissues were constructed using DMCs (5×107 
cells/mL), HAG, and BMP-4 of different concentrations (25 μg/mL in A, A1-A3; 12.5 
μg/mL in B, B1-B3; 6.25 μg/mL in C, C1-C3). Overall views of H&E (A, B and C) 
staining of the respective regenerated tissues. All tissues in A, B and C exhibited 
typical island-like features. A1, A2, B1, and C1 were higher magnification 
observations of the localized square areas within A, B, and C, respectively. A3, B2, 
B3, C2, and C3 were higher magnification observations of the localized square areas 
within A1, B1, and C1 respectively. There were well-organized dentinal-like tubules 
(white arrow head) arranged radially along the pulp-like tissue and columnar 
odontoblast-like cells with polarized basal nuclei (yellow arrow head) lining up along 
the dentinal wall (A1-A3). Although dentinal-like tubules (white arrow head) and 
columnar odontoblast-like cells (yellow arrow head) could also be observed within 
B1-B3 and C2, such structure was not well organized as that in A1-A3. Moreover, 
bone-like tissue formation in C1 and C3 was observed even with hypertrophic cells 
(C3), indicating that insufficient differentiation occurred in the current sample. Blood 
vessels were distributed within all of these tissues (black arrow head). Scale bars: 
1000 μm for A, B and C; 100 μm for A1, B1 and C1; 50 μm for A2-A3, B2-B3 and 
C2-C3. 
Figure 11. Masson and immunohistochemical staining of the regenerated tissues 
constructed subcutaneously in nude mice for 10 weeks. The tissues were constructed 
using DMCs (5×107 cells/mL), HAG, and BMP-4 of different concentrations (25 
μg/mL in A and D; 12.5 μg/mL in B and E; 6.25 μg/mL in C and F). A, B and C were 
overall views of Masson staining of the different tissues. A1, B1, and C1 are higher 
magnification observations of the localized square areas within A, B, and C, 
respectively. D, E, and F were overall views of immunohistochemical staining for 
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dentin sialoprotein (DSP) of the different tissues. D1, E1, and F1 were higher 
magnification observations of the localized square areas within D, E, and F 
respectively. DSP positive staining could be observed throughout the whole structures 
of D, E, and F, especially within areas of soft tissues. Strong DSP staining of those 
dentinal tubules could only be observed in D1. The positive DSP expression by 
odontoblast-like cells were indicated by yellow arrow heads, while DSP staining by 
dentinal tubules  were indicated by white arrow heads. Scale bars: 1000 μm for A, B, 
C, D, E and F; 50 μm for A1, B1, C1, D1, E1 and F1. 
Figure 12. Polarized histological morphology of the regenerated tissues constructed 
subcutaneously in nude mice for 10 weeks. The tissues were constructed using DMCs 
(5×107 cells/mL), HAG, and BMP-4 of different concentrations (25 μg/mL in A-A2; 
12.5 μg/mL in B-B2; 6.25 μg/mL in C-C2). A1, B1, and C1 were higher magnification 
polarized H&E observations of A, B, and C, respectively, while A2, B2, and C2 were 
higher magnification polarized H&E observations of A1, B1, and C1, respectively,. 
Scale bars: 200 μm for A, B and C; 100 μm for A1, B1 and C1; 50 μm for A2, B2 and 
C2. 
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Scheme 1. Illustration of the crosslinking reaction of HA with 1,4-butanediol diglycidyl ether 
BDDE. HA: hyaluronic acid; BDDE: 1,4-butanediol diglycidyl ether.  
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Table 1. Release of BDDE residue by crosslinked HA hydrogels  
 
BDDE 
concentration (%) 
First release 
(μg) 
Second 
release (μg) 
Third  
release (μg)
Fourth 
release (μg) 
Total 
release (µg)
0.4 158.5 83 15 / 256.5 
0.6 226 106.5 41.5 11 385 
0.8 294 147.5 57.5 16.5 515.5 
1.0 366 162 93.5 26.5 648 
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